|
US5906936A
(en)
|
1988-05-04 |
1999-05-25 |
Yeda Research And Development Co. Ltd. |
Endowing lymphocytes with antibody specificity
|
|
IL104570A0
(en)
|
1992-03-18 |
1993-05-13 |
Yeda Res & Dev |
Chimeric genes and cells transformed therewith
|
|
US8211422B2
(en)
|
1992-03-18 |
2012-07-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Chimeric receptor genes and cells transformed therewith
|
|
AU701578B2
(en)
|
1992-08-21 |
1999-02-04 |
Vrije Universiteit Brussel |
Immunoglobulins devoid of light chains
|
|
US5830755A
(en)
|
1995-03-27 |
1998-11-03 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
T-cell receptors and their use in therapeutic and diagnostic methods
|
|
US5840839A
(en)
|
1996-02-09 |
1998-11-24 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein
|
|
JP2001517206A
(ja)
|
1996-08-16 |
2001-10-02 |
ザ ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン |
免疫優性な共有黒色腫抗原を発現する黒色腫細胞株およびその使用方法
|
|
CN1237909A
(zh)
|
1996-10-11 |
1999-12-08 |
加利福尼亚大学董事会 |
联合使用肿瘤细胞与混合淋巴细胞的癌症免疫治疗
|
|
CA2304168A1
(en)
|
1997-09-19 |
1999-04-01 |
The Trustees Of The University Of Pennsylvania |
Methods and cell line useful for production of recombinant adeno-associated viruses
|
|
ES2340230T3
(es)
|
1998-11-10 |
2010-05-31 |
University Of North Carolina At Chapel Hill |
Vectores viricos y sus procedimientos de preparacion y administracion.
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
WO2000046386A2
(en)
|
1999-02-03 |
2000-08-10 |
The Children's Medical Center Corporation |
Gene repair involving the induction of double-stranded dna cleavage at a chromosomal target site
|
|
EP2311950A1
(en)
|
2000-01-28 |
2011-04-20 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
Novel MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1
|
|
CA2373110A1
(en)
*
|
2000-03-14 |
2001-09-20 |
Neurologix, Inc. |
Production of chimeric capsid vectors
|
|
WO2002030184A1
(en)
|
2000-10-09 |
2002-04-18 |
Amrad Operations Pty Ltd |
Modulating cytokine or hormone signalling in an animal comprising up-regulating the expression of socs sequence in the animal
|
|
US8716022B2
(en)
|
2000-11-17 |
2014-05-06 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Modulation of meiotic recombination
|
|
US7723111B2
(en)
|
2001-03-09 |
2010-05-25 |
The United States Of America As Represented By The Department Of Health And Human Services |
Activated dual specificity lymphocytes and their methods of use
|
|
US7070995B2
(en)
|
2001-04-11 |
2006-07-04 |
City Of Hope |
CE7-specific redirected immune cells
|
|
AU2002321581C1
(en)
|
2001-08-31 |
2008-09-18 |
Adaptimmune Limited |
Soluble T cell receptor
|
|
AU2003216436A1
(en)
|
2002-02-08 |
2003-09-02 |
Life Technologies Corporation |
Compositions and methods for restoring immune responsiveness in patients with immunological defects
|
|
US7446190B2
(en)
|
2002-05-28 |
2008-11-04 |
Sloan-Kettering Institute For Cancer Research |
Nucleic acids encoding chimeric T cell receptors
|
|
AU2003233734C1
(en)
|
2002-06-05 |
2011-01-20 |
Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of Agriculture And Agri-Food |
Retrons for gene targeting
|
|
CN1856576B
(zh)
*
|
2003-09-30 |
2011-05-04 |
宾夕法尼亚州立大学托管会 |
腺伴随病毒(aav)进化支、序列、含有这些序列的载体及它们的应用
|
|
US7435596B2
(en)
|
2004-11-04 |
2008-10-14 |
St. Jude Children's Research Hospital, Inc. |
Modified cell line and method for expansion of NK cell
|
|
NZ550815A
(en)
|
2004-05-19 |
2009-04-30 |
Immunocore Ltd |
Method of improving T cell receptors
|
|
DK1765860T3
(da)
|
2004-05-19 |
2009-03-09 |
Immunocore Ltd |
Ny-ESO-T.cellereceptor med höj affinitet
|
|
JP2008522951A
(ja)
|
2004-07-19 |
2008-07-03 |
ベイラー・カレツジ・オブ・メデイシン |
サイトカインシグナル伝達調節物質の調節および免疫療法のための応用
|
|
EP1828390B1
(en)
*
|
2004-12-15 |
2012-06-13 |
The University Of North Carolina At Chapel Hill |
Chimeric vectors
|
|
US8889365B2
(en)
|
2005-03-16 |
2014-11-18 |
Rutgers, The State University Of New Jersey |
Methods and kit for detecting breast cancer
|
|
WO2006110689A2
(en)
*
|
2005-04-07 |
2006-10-19 |
The Trustees Of The University Of Pennsylvania |
Method of increasing the function of an aav vector
|
|
US8283151B2
(en)
*
|
2005-04-29 |
2012-10-09 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Isolation, cloning and characterization of new adeno-associated virus (AAV) serotypes
|
|
US8389708B2
(en)
|
2005-06-15 |
2013-03-05 |
Weiping Min |
Method of cancer treatment using siRNA silencing
|
|
WO2007017201A1
(en)
|
2005-08-05 |
2007-02-15 |
Helmholtz Zentrum München Deutsches Forschungszentrum Für Gesundheit Und Umwelt Gmbh |
Generation of antigen specific t cells
|
|
ES2398918T3
(es)
|
2005-08-26 |
2013-03-22 |
Dupont Nutrition Biosciences Aps |
Un método y una ordenación para soportar verticalmente elementos de resistencia eléctrica pendientes
|
|
US20090220488A1
(en)
|
2005-08-31 |
2009-09-03 |
Humphrey Gardner |
Evaluating and treating scleroderma
|
|
US7867484B2
(en)
*
|
2006-01-27 |
2011-01-11 |
University Of North Carolina At Chapel Hill |
Heparin and heparan sulfate binding chimeric vectors
|
|
WO2008016391A2
(en)
*
|
2006-01-31 |
2008-02-07 |
The Board Of Trustees Of The Leland Stanford Junior University |
Self-complementary parvoviral vectors, and methods for making and using the same
|
|
MX2008013514A
(es)
|
2006-05-17 |
2008-10-28 |
Hoffmann La Roche |
Celulas productoras de polipeptidos.
|
|
PL2018441T3
(pl)
|
2006-05-19 |
2012-03-30 |
Dupont Nutrition Biosci Aps |
Mikroorganizmy znakowane i sposoby znakowania
|
|
EP2848253A1
(en)
|
2006-06-19 |
2015-03-18 |
Asklepios Biopharmaceutical, Inc. |
Modified factor VIII and factor IX genes and vectors for gene therapy
|
|
EP1878744A1
(en)
|
2006-07-13 |
2008-01-16 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Epitope-tag for surface-expressed T-cell receptor proteins, uses thereof and method of selecting host cells expressing them
|
|
US7750449B2
(en)
|
2007-03-13 |
2010-07-06 |
Micron Technology, Inc. |
Packaged semiconductor components having substantially rigid support members and methods of packaging semiconductor components
|
|
CA2682527C
(en)
|
2007-03-30 |
2017-07-11 |
Memorial Sloan-Kettering Cancer Center |
Constitutive expression of costimulatory ligands on adoptively transferred t lymphocytes
|
|
US8563314B2
(en)
|
2007-09-27 |
2013-10-22 |
Sangamo Biosciences, Inc. |
Methods and compositions for modulating PD1
|
|
EP2910637A1
(en)
|
2008-05-20 |
2015-08-26 |
University of Florida Research Foundation, Inc. |
Vectors for delivery of light-sensitive proteins and methods of use
|
|
WO2010011961A2
(en)
|
2008-07-25 |
2010-01-28 |
University Of Georgia Research Foundation, Inc. |
Prokaryotic rnai-like system and methods of use
|
|
EP4032552B1
(en)
|
2008-08-26 |
2023-10-04 |
City of Hope |
Method and compositions for enhanced anti-tumor effector functioning of t cells
|
|
US20100076057A1
(en)
|
2008-09-23 |
2010-03-25 |
Northwestern University |
TARGET DNA INTERFERENCE WITH crRNA
|
|
WO2010054108A2
(en)
|
2008-11-06 |
2010-05-14 |
University Of Georgia Research Foundation, Inc. |
Cas6 polypeptides and methods of use
|
|
EP2396343B1
(en)
*
|
2009-02-11 |
2017-05-17 |
The University of North Carolina At Chapel Hill |
Modified virus vectors and methods of making and using the same
|
|
PL2403867T3
(pl)
|
2009-03-04 |
2019-12-31 |
Deutsches Krebsforschungszentrum |
Białko aktywujące składanie (aap) i jego zastosowanie do wytwarzania cząstek parwowirusa zasadniczo składających się z vp3
|
|
EP2258719A1
(en)
|
2009-05-19 |
2010-12-08 |
Max-Delbrück-Centrum für Molekulare Medizin (MDC) |
Multiple target T cell receptor
|
|
US20120192298A1
(en)
|
2009-07-24 |
2012-07-26 |
Sigma Aldrich Co. Llc |
Method for genome editing
|
|
US8383099B2
(en)
|
2009-08-28 |
2013-02-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Adoptive cell therapy with young T cells
|
|
US8956828B2
(en)
|
2009-11-10 |
2015-02-17 |
Sangamo Biosciences, Inc. |
Targeted disruption of T cell receptor genes using engineered zinc finger protein nucleases
|
|
WO2011117258A2
(en)
*
|
2010-03-22 |
2011-09-29 |
Association Institut De Myologie |
Methods of increasing efficiency of vector penetration of target tissue
|
|
EP3467101A3
(en)
|
2010-09-08 |
2019-06-19 |
Baylor College of Medicine |
Immunotherapy of brain tumor using geneticially engineered gd2-specific t cells
|
|
WO2012031760A1
(en)
|
2010-09-08 |
2012-03-15 |
Medigene Ag |
Parvovirus mutated structural proteins comprising cross - protective b - cell epitopes of a hpv l2 protein as well as products and methods relating thereto
|
|
GB2498325B
(en)
|
2010-10-15 |
2018-05-02 |
Eos Neuroscience Inc |
Engineered human GRM6 enhancer sequence for use in eye therapies
|
|
WO2012078540A1
(en)
|
2010-12-08 |
2012-06-14 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Modulating immune cell activity using cytokine-induced src homology 2 and/or high temperature requirement a-1
|
|
PH12013501201A1
(en)
|
2010-12-09 |
2013-07-29 |
Univ Pennsylvania |
Use of chimeric antigen receptor-modified t cells to treat cancer
|
|
WO2012112079A1
(en)
|
2011-02-14 |
2012-08-23 |
Vitaspero, Inc. |
IMPROVING CELLULAR IMMUNOTHERAPEUTIC VACCINES EFFICACY WITH GENE SUPPRESSION IN DENDRITIC CELLS AND T-LYMPHOCYTES USING SiRNA
|
|
US9528124B2
(en)
|
2013-08-27 |
2016-12-27 |
Recombinetics, Inc. |
Efficient non-meiotic allele introgression
|
|
CN110200997A
(zh)
|
2011-03-23 |
2019-09-06 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
|
CN103476399A
(zh)
*
|
2011-04-18 |
2013-12-25 |
独立行政法人国立精神·神经医疗研究中心 |
药剂递送粒子及其制造方法
|
|
WO2012164565A1
(en)
|
2011-06-01 |
2012-12-06 |
Yeda Research And Development Co. Ltd. |
Compositions and methods for downregulating prokaryotic genes
|
|
CN103732238A
(zh)
|
2011-06-08 |
2014-04-16 |
奥瑞基尼探索技术有限公司 |
用于免疫调节的治疗性化合物
|
|
KR101307196B1
(ko)
|
2011-07-15 |
2013-09-12 |
국립대학법인 울산과학기술대학교 산학협력단 |
미세 세포 배양 장치
|
|
WO2013040557A2
(en)
|
2011-09-16 |
2013-03-21 |
The Trustees Of The University Of Pennsylvania |
Rna engineered t cells for the treatment of cancer
|
|
WO2013049330A1
(en)
|
2011-09-28 |
2013-04-04 |
The Regents Of The University Of California |
Synthetic transcriptional control elements and methods of generating and using such elements
|
|
EP2768982A4
(en)
|
2011-10-21 |
2015-06-03 |
Adaptive Biotechnologies Corp |
QUANTIFICATION OF ADAPTIVE IMMUNOCELL GENOMES IN A COMPLEX MIX OF CELLS
|
|
JP6074435B2
(ja)
|
2011-10-26 |
2017-02-01 |
ナショナル キャンサー センター |
変異ｃｔｌａ４遺伝子移入ｔ細胞及びこれを含む抗がん免疫治療用組成物
|
|
US9441206B2
(en)
|
2011-10-28 |
2016-09-13 |
The University Of North Carolina At Chapel Hill |
Cell line for production of adeno-associated virus
|
|
WO2013074916A1
(en)
|
2011-11-18 |
2013-05-23 |
Board Of Regents, The University Of Texas System |
Car+ t cells genetically modified to eliminate expression of t- cell receptor and/or hla
|
|
PH12014501360B1
(en)
|
2011-12-16 |
2022-05-20 |
Targetgene Biotechnologies Ltd |
Compositions and methods for modifying a predetermined target nucleic acid sequence
|
|
WO2013096955A1
(en)
|
2011-12-23 |
2013-06-27 |
Case Western Reserve University |
Targeted gene modification using hybrid recombinant adeno-associated virus
|
|
GB201122458D0
(en)
|
2011-12-30 |
2012-02-08 |
Univ Wageningen |
Modified cascade ribonucleoproteins and uses thereof
|
|
US9637739B2
(en)
|
2012-03-20 |
2017-05-02 |
Vilnius University |
RNA-directed DNA cleavage by the Cas9-crRNA complex
|
|
WO2013141680A1
(en)
|
2012-03-20 |
2013-09-26 |
Vilnius University |
RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
|
|
JP6378172B2
(ja)
|
2012-05-22 |
2018-08-22 |
アメリカ合衆国 |
マウス抗ｎｙ−ｅｓｏ−１ｔ細胞受容体
|
|
US20150017136A1
(en)
|
2013-07-15 |
2015-01-15 |
Cellectis |
Methods for engineering allogeneic and highly active t cell for immunotherapy
|
|
EP3241902B1
(en)
|
2012-05-25 |
2018-02-28 |
The Regents of The University of California |
Methods and compositions for rna-directed target dna modification and for rna-directed modulation of transcription
|
|
KR102437522B1
(ko)
|
2012-05-25 |
2022-08-26 |
셀렉티스 |
면역요법을 위한 동종이형 및 면역억제제 저항성인 ｔ 세포의 조작 방법
|
|
WO2014006518A1
(en)
|
2012-07-04 |
2014-01-09 |
Indian Institute Of Science |
Compounds as inhibitor of dna double-strand break repair, methods and applications thereof
|
|
KR102530118B1
(ko)
|
2012-07-25 |
2023-05-08 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유도 ｄｎａ 결합 단백질 및 게놈 교란 도구 및 이의 적용
|
|
HK1207111A1
(en)
|
2012-08-03 |
2016-01-22 |
加利福尼亚大学董事会 |
Methods and compositions for controlling gene expression by rna processing
|
|
CA2881981A1
(en)
|
2012-08-20 |
2014-02-27 |
Fred Hutchinson Cancer Research Center |
Method and compositions for cellular immunotherapy
|
|
EP2906684B8
(en)
|
2012-10-10 |
2020-09-02 |
Sangamo Therapeutics, Inc. |
T cell modifying compounds and uses thereof
|
|
US20140113375A1
(en)
|
2012-10-21 |
2014-04-24 |
Lixin Liu |
Transient Expression And Reverse Transcription Aided Genome Alteration System
|
|
EP4357457B1
(en)
|
2012-10-23 |
2024-10-16 |
Toolgen Incorporated |
Composition for cleaving a target dna comprising a guide rna specific for the target dna and cas protein-encoding nucleic acid or cas protein, and use thereof
|
|
GB2508414A
(en)
|
2012-11-30 |
2014-06-04 |
Max Delbrueck Centrum |
Tumour specific T cell receptors (TCRs)
|
|
EP3363902B1
(en)
|
2012-12-06 |
2019-11-27 |
Sigma Aldrich Co. LLC |
Crispr-based genome modification and regulation
|
|
CA2894684A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Engineering and optimization of improved crispr-cas systems, methods and enzyme compositions for sequence manipulation in eukaryotes
|
|
DK2931898T3
(en)
|
2012-12-12 |
2016-06-20 |
Massachusetts Inst Technology |
CONSTRUCTION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION WITH FUNCTIONAL DOMAINS
|
|
US8697359B1
(en)
|
2012-12-12 |
2014-04-15 |
The Broad Institute, Inc. |
CRISPR-Cas systems and methods for altering expression of gene products
|
|
WO2014093694A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Crispr-cas nickase systems, methods and compositions for sequence manipulation in eukaryotes
|
|
AU2013359262C1
(en)
|
2012-12-12 |
2021-05-13 |
Massachusetts Institute Of Technology |
CRISPR-Cas component systems, methods and compositions for sequence manipulation
|
|
WO2014093709A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, models, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
DK2931897T3
(en)
|
2012-12-12 |
2018-02-05 |
Broad Inst Inc |
CONSTRUCTION, MODIFICATION AND OPTIMIZATION OF SYSTEMS, PROCEDURES AND COMPOSITIONS FOR SEQUENCE MANIPULATION AND THERAPEUTICAL APPLICATIONS
|
|
WO2014093718A1
(en)
|
2012-12-12 |
2014-06-19 |
The Broad Institute, Inc. |
Methods, systems, and apparatus for identifying target sequences for cas enzymes or crispr-cas systems for target sequences and conveying results thereof
|
|
CN105121648B
(zh)
|
2012-12-12 |
2021-05-07 |
布罗德研究所有限公司 |
用于序列操纵的系统、方法和优化的指导组合物的工程化
|
|
CA2895155C
(en)
|
2012-12-17 |
2021-07-06 |
President And Fellows Of Harvard College |
Rna-guided human genome engineering
|
|
WO2014127287A1
(en)
|
2013-02-14 |
2014-08-21 |
Massachusetts Institute Of Technology |
Method for in vivo tergated mutagenesis
|
|
US10227610B2
(en)
|
2013-02-25 |
2019-03-12 |
Sangamo Therapeutics, Inc. |
Methods and compositions for enhancing nuclease-mediated gene disruption
|
|
PT2961831T
(pt)
|
2013-02-26 |
2020-10-12 |
Memorial Sloan Kettering Cancer Center |
Composições e métodos para imunoterapêutica
|
|
WO2014134412A1
(en)
|
2013-03-01 |
2014-09-04 |
Regents Of The University Of Minnesota |
Talen-based gene correction
|
|
WO2014153118A1
(en)
|
2013-03-14 |
2014-09-25 |
The Board Of Trustees Of The Leland Stanford Junior University |
Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
|
|
MX374090B
(es)
|
2013-03-14 |
2025-03-05 |
Caribou Biosciences Inc |
Composiciones y métodos de ácidos nucleicos dirigidos al ácido nucleico.
|
|
US20140271550A1
(en)
*
|
2013-03-14 |
2014-09-18 |
The Trustees Of The University Of Pennsylvania |
Constructs and Methods for Delivering Molecules via Viral Vectors with Blunted Innate Immune Responses
|
|
WO2014159546A1
(en)
|
2013-03-14 |
2014-10-02 |
Asklepios Biopharmaceutical, Inc. |
Modified soluble vegf receptor-1 genes and vectors for gene therapy
|
|
AU2014227653B2
(en)
|
2013-03-15 |
2017-04-20 |
The General Hospital Corporation |
Using RNA-guided foki nucleases (RFNs) to increase specificity for RNA-guided genome editing
|
|
US9234213B2
(en)
|
2013-03-15 |
2016-01-12 |
System Biosciences, Llc |
Compositions and methods directed to CRISPR/Cas genomic engineering systems
|
|
US20140273230A1
(en)
|
2013-03-15 |
2014-09-18 |
Sigma-Aldrich Co., Llc |
Crispr-based genome modification and regulation
|
|
JP2016522679A
(ja)
|
2013-04-04 |
2016-08-04 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＣＲＩＳＰＲ／Ｃａｓ系を用いたゲノム編集の治療的使用
|
|
AU2014251099B2
(en)
*
|
2013-04-08 |
2019-01-17 |
The University Of Kansas |
Chimeric adeno-associated virus/ bocavirus parvovirus vector
|
|
MX2015015638A
(es)
|
2013-05-13 |
2016-10-28 |
Cellectis |
Metodos para diseñar celulas t altamente activas para inmunoterapia.
|
|
US11311575B2
(en)
|
2013-05-13 |
2022-04-26 |
Cellectis |
Methods for engineering highly active T cell for immunotherapy
|
|
CN105683376A
(zh)
|
2013-05-15 |
2016-06-15 |
桑格摩生物科学股份有限公司 |
用于治疗遗传病状的方法和组合物
|
|
WO2014191128A1
(en)
|
2013-05-29 |
2014-12-04 |
Cellectis |
Methods for engineering t cells for immunotherapy by using rna-guided cas nuclease system
|
|
US20160122774A1
(en)
|
2013-05-29 |
2016-05-05 |
Cellectis |
A method for producing precise dna cleavage using cas9 nickase activity
|
|
ES2883131T3
(es)
|
2013-05-29 |
2021-12-07 |
Cellectis |
Métodos para la modificación de células T para inmunoterapia utilizando el sistema de nucleasa CAS guiado por ARN
|
|
JP6195474B2
(ja)
|
2013-05-31 |
2017-09-13 |
ギガフォトン株式会社 |
極端紫外光生成装置及び極端紫外光生成システムにおけるレーザシステムの制御方法
|
|
MX2015017312A
(es)
|
2013-06-17 |
2017-04-10 |
Broad Inst Inc |
Suministro y uso de composiciones, vectores y sistemas crispr-cas para la modificación dirigida y terapia hepáticas.
|
|
KR20250012194A
(ko)
|
2013-06-17 |
2025-01-23 |
더 브로드 인스티튜트, 인코퍼레이티드 |
바이러스 구성성분을 사용하여 장애 및 질환을 표적화하기 위한 crispr-cas 시스템 및 조성물의 전달, 용도 및 치료 적용
|
|
KR20160019553A
(ko)
|
2013-06-17 |
2016-02-19 |
더 브로드 인스티튜트, 인코퍼레이티드 |
유사분열 후 세포의 질병 및 장애를 표적화하고 모델링하기 위한 시스템, 방법 및 조성물의 전달, 유전자 조작 및 최적화
|
|
EP3011030B1
(en)
|
2013-06-17 |
2023-11-08 |
The Broad Institute, Inc. |
Optimized crispr-cas double nickase systems, methods and compositions for sequence manipulation
|
|
WO2014204724A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
|
|
EP3725885A1
(en)
|
2013-06-17 |
2020-10-21 |
The Broad Institute, Inc. |
Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
|
|
WO2014204723A1
(en)
|
2013-06-17 |
2014-12-24 |
The Broad Institute Inc. |
Oncogenic models based on delivery and use of the crispr-cas systems, vectors and compositions
|
|
JP2016528890A
(ja)
|
2013-07-09 |
2016-09-23 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
ＣＲＩＳＰＲ／Ｃａｓ系を用いるゲノム編集の治療用の使用
|
|
WO2015006294A2
(en)
|
2013-07-10 |
2015-01-15 |
President And Fellows Of Harvard College |
Orthogonal cas9 proteins for rna-guided gene regulation and editing
|
|
HK1222673A1
(zh)
|
2013-07-12 |
2017-07-07 |
The Children's Hospital Of Philadelphia |
Aav载体和用於抗aav(腺相关病毒)中和抗体的检测
|
|
US10501753B2
(en)
|
2013-07-12 |
2019-12-10 |
Oms Investments, Inc. |
Plants comprising events PP009-401, PP009-415, and PP009-469, compositions, sequences, and methods for detection thereof
|
|
US10563225B2
(en)
|
2013-07-26 |
2020-02-18 |
President And Fellows Of Harvard College |
Genome engineering
|
|
WO2015021426A1
(en)
|
2013-08-09 |
2015-02-12 |
Sage Labs, Inc. |
A crispr/cas system-based novel fusion protein and its application in genome editing
|
|
CA3109801C
(en)
|
2013-08-22 |
2024-01-09 |
Andrew Cigan |
Plant genome modification using guide rna/cas endonuclease systems and methods of use
|
|
US10822606B2
(en)
|
2013-09-27 |
2020-11-03 |
The Regents Of The University Of California |
Optimized small guide RNAs and methods of use
|
|
WO2015048577A2
(en)
|
2013-09-27 |
2015-04-02 |
Editas Medicine, Inc. |
Crispr-related methods and compositions
|
|
US20150098954A1
(en)
|
2013-10-08 |
2015-04-09 |
Elwha Llc |
Compositions and Methods Related to CRISPR Targeting
|
|
DE102013111099B4
(de)
|
2013-10-08 |
2023-11-30 |
Eberhard Karls Universität Tübingen Medizinische Fakultät |
Permanente Genkorrektur mittels nukleotidmodifizierter messenger RNA
|
|
CN104592364B
(zh)
*
|
2013-10-30 |
2018-05-01 |
北京大学 |
定点突变和定点修饰的腺相关病毒、其制备方法及应用
|
|
AU2014346559B2
(en)
|
2013-11-07 |
2020-07-09 |
Editas Medicine,Inc. |
CRISPR-related methods and compositions with governing gRNAs
|
|
EP3760719A1
(en)
|
2013-11-18 |
2021-01-06 |
CRISPR Therapeutics AG |
Crispr-cas system materials and methods
|
|
US10787684B2
(en)
|
2013-11-19 |
2020-09-29 |
President And Fellows Of Harvard College |
Large gene excision and insertion
|
|
CN106103699B
(zh)
|
2013-11-28 |
2019-11-26 |
地平线探索有限公司 |
体细胞单倍体人类细胞系
|
|
WO2015084897A2
(en)
|
2013-12-02 |
2015-06-11 |
Mirimmune, Llc |
Immunotherapy of cancer
|
|
US20150165054A1
(en)
|
2013-12-12 |
2015-06-18 |
President And Fellows Of Harvard College |
Methods for correcting caspase-9 point mutations
|
|
EP3470089A1
(en)
|
2013-12-12 |
2019-04-17 |
The Broad Institute Inc. |
Delivery, use and therapeutic applications of the crispr-cas systems and compositions for targeting disorders and diseases using particle delivery components
|
|
CN103820454B
(zh)
|
2014-03-04 |
2016-03-30 |
上海金卫生物技术有限公司 |
CRISPR-Cas9特异性敲除人PD1基因的方法以及用于特异性靶向PD1基因的sgRNA
|
|
MX373460B
(es)
|
2014-03-11 |
2020-04-07 |
Cellectis |
Metodo para generar celulas t compatibles para el trasplante alogenico.
|
|
EP3593812A3
(en)
|
2014-03-15 |
2020-05-27 |
Novartis AG |
Treatment of cancer using chimeric antigen receptor
|
|
JP2017511375A
(ja)
|
2014-03-20 |
2017-04-20 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
養子細胞療法のための腫瘍浸潤リンパ球
|
|
WO2015148454A1
(en)
|
2014-03-28 |
2015-10-01 |
Asklepios Biopharmaceutical, Inc. |
Optimized and modified factor viii genes for gene therapy
|
|
US11439712B2
(en)
|
2014-04-08 |
2022-09-13 |
North Carolina State University |
Methods and compositions for RNA-directed repression of transcription using CRISPR-associated genes
|
|
US10253311B2
(en)
|
2014-04-10 |
2019-04-09 |
The Regents Of The University Of California |
Methods and compositions for using argonaute to modify a single stranded target nucleic acid
|
|
CA2945335A1
(en)
|
2014-04-18 |
2015-10-22 |
Editas Medicine, Inc. |
Crispr-cas-related methods, compositions and components for cancer immunotherapy
|
|
RU2763795C2
(ru)
|
2014-04-23 |
2022-01-11 |
Джуно Терапьютикс, Инк. |
Способы выделения, культивирования и генетической инженерии популяций клеток иммунной системы для адоптивной терапии
|
|
EP3152319A4
(en)
|
2014-06-05 |
2017-12-27 |
Sangamo BioSciences, Inc. |
Methods and compositions for nuclease design
|
|
WO2015191508A1
(en)
|
2014-06-09 |
2015-12-17 |
Voyager Therapeutics, Inc. |
Chimeric capsids
|
|
WO2015191693A2
(en)
|
2014-06-10 |
2015-12-17 |
Massachusetts Institute Of Technology |
Method for gene editing
|
|
WO2015188228A1
(en)
|
2014-06-10 |
2015-12-17 |
Monash University |
Method of producing leukocytes using ptpn2 inhibition for adoptive cell transfer
|
|
TWI530276B
(zh)
|
2014-07-08 |
2016-04-21 |
原相科技股份有限公司 |
具去噪功能之生理偵測模組及其生理偵測方法
|
|
AU2015289644A1
(en)
|
2014-07-15 |
2017-02-02 |
Juno Therapeutics, Inc. |
Engineered cells for adoptive cell therapy
|
|
WO2016054326A1
(en)
|
2014-10-01 |
2016-04-07 |
The General Hospital Corporation |
Methods for increasing efficiency of nuclease-induced homology-directed repair
|
|
AU2014407539B2
(en)
|
2014-10-02 |
2020-10-22 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Methods of isolating T cell receptors having antigenic specificity for a cancer-specific mutation
|
|
EP3204496A1
(en)
|
2014-10-10 |
2017-08-16 |
Editas Medicine, Inc. |
Compositions and methods for promoting homology directed repair
|
|
WO2016069282A1
(en)
|
2014-10-31 |
2016-05-06 |
The Trustees Of The University Of Pennsylvania |
Altering gene expression in modified t cells and uses thereof
|
|
US10900034B2
(en)
|
2014-12-03 |
2021-01-26 |
Agilent Technologies, Inc. |
Guide RNA with chemical modifications
|
|
SG11201704272YA
(en)
|
2014-12-31 |
2017-06-29 |
Synthetic Genomics Inc |
Compositions and methods for high efficiency in vivo genome editing
|
|
WO2016112351A1
(en)
|
2015-01-09 |
2016-07-14 |
Bio-Rad Laboratories, Inc. |
Detection of genome editing
|
|
CN107429263A
(zh)
|
2015-01-15 |
2017-12-01 |
斯坦福大学托管董事会 |
调控基因组编辑的方法
|
|
KR102422108B1
(ko)
|
2015-01-20 |
2022-07-19 |
삼성디스플레이 주식회사 |
유기 발광 표시 장치
|
|
EP3259284B1
(en)
|
2015-02-16 |
2020-04-01 |
The Trustees of the University of Pennsylvania |
A fully-human t cell receptor specific for the 369-377 epitope derived from the her2/neu (erbb2) receptor protein
|
|
KR20260048600A
(ko)
|
2015-03-27 |
2026-04-10 |
프레지던트 앤드 펠로우즈 오브 하바드 칼리지 |
변형된 t 세포 및 이의 제조 및 사용 방법
|
|
GB201508026D0
(en)
*
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Capsid
|
|
US20180119174A1
(en)
|
2015-05-13 |
2018-05-03 |
Seattle Children's Hospita (dba Seattle Children's Research Institute |
Enhancing endonuclease based gene editing in primary cells
|
|
US9790490B2
(en)
|
2015-06-18 |
2017-10-17 |
The Broad Institute Inc. |
CRISPR enzymes and systems
|
|
EP3322297B1
(en)
*
|
2015-07-13 |
2024-12-04 |
Sangamo Therapeutics, Inc. |
Delivery methods and compositions for nuclease-mediated genome engineering
|
|
GB2592821B
(en)
|
2015-07-31 |
2022-01-12 |
Univ Minnesota |
Modified cells and methods of therapy
|
|
JP7185524B2
(ja)
|
2015-09-15 |
2022-12-07 |
アメリカ合衆国 |
Ｈｌａ－ｃｗ８拘束性の変異ｋｒａｓを認識するｔ細胞受容体
|
|
WO2017053729A1
(en)
|
2015-09-25 |
2017-03-30 |
The Board Of Trustees Of The Leland Stanford Junior University |
Nuclease-mediated genome editing of primary cells and enrichment thereof
|
|
US11015173B2
(en)
|
2015-12-11 |
2021-05-25 |
The Trustees Of The University Of Pennsylvania |
Scalable purification method for AAV1
|
|
ES2952064T3
(es)
|
2015-12-16 |
2023-10-26 |
Walter & Eliza Hall Inst Medical Res |
Inhibición de la proteína SH2 inducida por citocinas en células NK
|
|
US9570114B1
(en)
|
2016-01-15 |
2017-02-14 |
HGST Netherlands B.V. |
Laminated film-packed hard disk drive for hermetic sealing
|
|
WO2017139264A1
(en)
|
2016-02-09 |
2017-08-17 |
President And Fellows Of Harvard College |
Dna-guided gene editing and regulation
|
|
WO2017180854A1
(en)
*
|
2016-04-15 |
2017-10-19 |
The Trustees Of The University Of Pennsylvania |
Novel aav8 mutant capsids and compositions containing same
|
|
JP2019524721A
(ja)
*
|
2016-07-15 |
2019-09-05 |
ポセイダ セラピューティクス， インコーポレイテッド |
キメラ抗原受容体および使用方法
|
|
CA3041831A1
(en)
|
2016-10-27 |
2018-05-03 |
Intima Bioscience, Inc. |
Viral methods of making genetically modified cells
|
|
WO2018109207A1
(en)
|
2016-12-16 |
2018-06-21 |
Uniqure Ip B.V. |
Immunoadsorption
|
|
US10550405B2
(en)
|
2017-03-15 |
2020-02-04 |
The University Of North Carolina At Chapel Hill |
Rational polyploid adeno-associated virus vectors and methods of making and using the same
|
|
CN110770346B
(zh)
*
|
2017-03-15 |
2024-01-12 |
北卡罗来纳-查佩尔山大学 |
多倍体腺相关病毒载体及其制备和使用方法
|
|
US20200370039A1
(en)
*
|
2017-04-11 |
2020-11-26 |
Ruprecht-Karls-Universitat Heidelberg |
Adeno-associated virus library
|
|
WO2019006418A2
(en)
|
2017-06-30 |
2019-01-03 |
Intima Bioscience, Inc. |
ADENO-ASSOCIATED VIRAL VECTORS FOR GENE THERAPY
|
|
KR20200036912A
(ko)
|
2017-07-31 |
2020-04-07 |
리플렉션 바이오테크놀러지스 리미티드 |
안과 질환을 위한 세포 모델 및 치료요법
|
|
US11760987B2
(en)
|
2017-09-07 |
2023-09-19 |
The Regents Of The University Of California |
Compositions and methods for the treatment or prevention of heart failure
|
|
JP2020536502A
(ja)
|
2017-09-07 |
2020-12-17 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
遺伝子操作のためのヌクレアーゼシステム
|
|
SG11202006056RA
(en)
*
|
2018-01-17 |
2020-07-29 |
Meiragtx Uk Ii Ltd |
A modified raav capsid protein for gene therapy
|